Fibrosis linked with mortality, liver-related morbidity risk in patients with NAFLD

Biopsy-confirmed fibrosis was associated with risk for mortality and liver-related morbidity in patients with NAFLD, regardless of confounding factors and in patients with NASH, according to study results.Rod S. Taylor, MSc, PHD, chair of population health research at the University of Glasgow, and colleagues wrote that it is widely accepted that liver fibrosis develops as a result of liver injury secondary to steatohepatitis in patients with NAFLD.“Given that disease activity in NASH may fluctuate over time and liver biopsy may be subject to sampling variability, some patients withRead More

Share on facebook
Share on twitter
Share on linkedin